Cargando…
Comparison of Cantharidin Toxicity in Breast Cancer Cells to Two Common Chemotherapeutics
As part of a larger study synthesizing a more directed form of chemotherapy, we have begun to assess the efficacy of different potential toxins that could be delivered locally rather than systemically. In doing so, we hope to reduce the systemic side effects commonly observed, while maintaining a hi...
Autores principales: | Kern, Katie M., Schroeder, Jennifer R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180196/ https://www.ncbi.nlm.nih.gov/pubmed/25302124 http://dx.doi.org/10.1155/2014/423059 |
Ejemplares similares
-
Molecular biology of cantharidin in cancer cells
por: Rauh, Rolf, et al.
Publicado: (2007) -
Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma
por: Zhang, Xue, et al.
Publicado: (2017) -
Norcantharidin, Derivative of Cantharidin, for Cancer Stem Cells
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013) -
THE RENAL LESION OF EXPERIMENTAL CANTHARIDIN POISONING
por: Pearce, Richard M.
Publicado: (1913) -
Non-ionic surfactant vesicles simultaneously enhance antitumor activity and reduce the toxicity of cantharidin
por: Han, Wei, et al.
Publicado: (2013)